Results 151 to 160 of about 8,372,308 (290)
Recurrence Risk in Lateralized Floor of Mouth Carcinoma: Depth of Invasion Versus Midline Distance
ABSTRACT Background Contralateral nodal recurrence in lateralized floor‐of‐mouth squamous cell carcinoma (OSCC) remains difficult to predict, and objective preoperative parameters to guide contralateral neck management in tumors without midline crossing are lacking.
Jannik Ketschau +10 more
wiley +1 more source
Malignant Transformation of Oral Leukoplakia into Oral Squamous Cell [PDF]
Development of squamous cell carcinoma around dental implants is an uncommon clinical manifestation with only a few cases described in the literature.
김진, 차인호
core
ABSTRACT Background Patients with head and neck cancer (HNC) are at risk of impaired muscle health due to metabolic disturbances, reduced nutritional intake, and treatment‐related toxicities. Because muscle health supports physical capacity and independence, its decline may affect quality of life (QoL).
Tycho Zuijlen +4 more
wiley +1 more source
Claudin-1 and Ki-67 expression in oral leukoplakia and oral squamous cell carcinoma
The correlation was investigated between the level of cell proliferation and the intensity of claudin-1 expression in oral Leukoplakia with different grade of cell neoplastic transformation (according to WHO classification 2005, - SIN - Squamous ...
A A Katushkina +3 more
doaj
ABSTRACT Adjuvant nivolumab is approved for esophageal or gastroesophageal junction cancer after neoadjuvant chemoradiotherapy and resection. In the CheckMate‐577 trial, Grade 3–5 nivolumab‐related adverse events (AEs) occurred in 5% of patients, with early discontinuation due to toxicity in 9%. However, real‐world data on immunotherapy‐related adverse
Michelle Koops van ’t Jagt +7 more
wiley +1 more source
SQUAMOUS CELL CARCINOMA ANTIGEN IN ORAL SQUAMOUS CELL CARCINOMAS
Squamous cell carcinoma (SCC) antigen is a tumor-associated antigen isolated from the squamous cell carcinoma of the uterine cervix. In order to estimate the usefulness of the SCC antigen in monitoring the clinical behaviors of oral squamous cell carcinomas, we analyzed clinicopathologically and immunohistochemically 54 cases of squamous cell carcinoma
openaire +1 more source
ABSTRACT This multicenter retrospective study evaluated the impact of type 2 diabetes mellitus (DM) on clinical outcomes and immune‐related adverse events (irAEs) in 450 patients with metastatic non‐small cell lung cancer (NSCLC) treated with second‐line nivolumab at 17 centers between 2016 and 2024. Among these patients, 118 (26.2%) had DM.
Emre Çakır +32 more
wiley +1 more source
ABSTRACT Long‐term survival data for patients with locally advanced gastro‐esophageal adenocarcinoma (GEA) treated with neoadjuvant chemoimmunotherapy are lacking. We describe the long‐term disease‐free survival (DFS) and overall survival (OS) outcomes of such patients treated with a novel neoadjuvant chemoimmunotherapy regimen, aDCF (avelumab with ...
Thierry Alcindor +8 more
wiley +1 more source
ABSTRACT Gastrointestinal (GI) cancers, including esophageal (EC), gastric (GC), and colorectal cancer (CRC), impose a substantial global burden, with early detection remaining crucial for improving patient outcomes. The oral and gut microbiota are increasingly implicated in cancer development and hold promise as sources of non‐invasive biomarkers ...
Saidi Hu +12 more
wiley +1 more source
ABSTRACT Clinical data on combined Immunotherapy (IO) and palliative radiotherapy (RT) in HNSCC is scarce. HNSCC Palliative RT differs from curative intent RT as it does not involve elective nodal irradiation; therefore, an immune response may be more likely.
Chris Hurt +21 more
wiley +1 more source

